{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:57:18Z","timestamp":1791424638171,"version":"4.3.3"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1111\/j.1365-2133.2010.09992.x","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T00:06:26Z","timestamp":1282003586000},"page":"1282-1290","source":"Crossref","is-referenced-by-count":125,"title":["Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-\u03b1 levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy"],"prefix":"10.1093","volume":"163","author":[{"given":"S.","family":"Coimbra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Belo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Quintanilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rocha-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Santos-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,11,8]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0625.2007.00629.x","article-title":"Immunopathogenesis of psoriasis","volume":"16","author":"Sabat","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.clindermatol.2007.08.012","article-title":"Immunopathogenesis and role of T cells in psoriasis","volume":"25","author":"Ghoreschi","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/jid.2008.85","article-title":"T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis","volume":"128","author":"Blauvelt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaad.2007.07.016","article-title":"Interleukin-12, interleukin-23, and psoriasis: current prospects","volume":"57","author":"Torti","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1648","article-title":"New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions","volume":"5","author":"Hunter","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2008.04.005","article-title":"Cytokines and anticytokines in psoriasis","volume":"394","author":"Pietrzak","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2230.2009.03704.x","article-title":"Serum cytokines and growth factor levels in Japanese patients with psoriasis","volume":"35","author":"Takahashi","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10875-008-9233-0","article-title":"Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial","volume":"29","author":"Caproni","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2133.2010.09767.x","article-title":"Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis","volume":"163","author":"V\u00e4h\u00e4vihu","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB17|cit17","first-page":"225","article-title":"Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs","volume":"158","author":"Toebak","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.mehy.2006.04.069","article-title":"Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations","volume":"67","author":"Kastelan","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1358\/dot.1999.35.12.564038","article-title":"The pathophysiological role of cytokines in psoriasis","volume":"35","author":"Asadullah","year":"1999","journal-title":"Drugs Today (Barc)"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1155\/MI.2005.298","article-title":"Repeated doses of UVR cause minor alteration in cytokine serum levels in humans","volume":"2005","author":"Narbutt","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09629350310001619753","article-title":"Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity","volume":"12","author":"Jacob","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-4632.2004.02082.x","article-title":"Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia","volume":"44","author":"Abanmi","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1365-2133.1999.03205.x","article-title":"Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis","volume":"141","author":"Bhushan","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1365-2133.2007.08135.x","article-title":"Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research","volume":"157","author":"Guttman-Yassky","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cardiores.2004.12.002","article-title":"The biology of vascular endothelial growth factors","volume":"65","author":"Tammela","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jid.5700096","article-title":"Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis","volume":"126","author":"Young","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archderm.138.6.791","article-title":"Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor","volume":"138","author":"Creamer","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/PL00012428","article-title":"Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis","volume":"51","author":"Nielsen","year":"2002","journal-title":"Inflamm Res"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1468-3083.2009.03181.x","article-title":"Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control","volume":"23","author":"Nofal","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1600-0625.2005.00356.x","article-title":"Vascular endothelial growth factor 121 is the predominant isoform in psoriatic scales","volume":"14","author":"Zhang","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/039463200601900405","article-title":"VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study","volume":"19","author":"Simonetti","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis - oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.clindermatol.2007.08.003","article-title":"The clinical spectrum of psoriasis","volume":"25","author":"Naldi","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2003.09.014","article-title":"A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis","volume":"50","author":"Carlin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.clindermatol.2007.08.002","article-title":"Three decades of psoriasis research: where has it led us?","volume":"25","author":"Sabat","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2133.2008.08628.x","article-title":"Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis","volume":"159","author":"Strober","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jdermsci.2009.05.008","article-title":"Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease","volume":"55","author":"Coimbra","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB38|cit38","first-page":"292","article-title":"Effect of liangxue huoxue xiaoyin tang on serum levels of TNF-alpha, IFN-gamma and IL-6 in psoriasis of blood-heat type","volume":"25","author":"Qiu","year":"2005","journal-title":"J Tradit Chin Med"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB39|cit39","first-page":"169","article-title":"Evaluation of cytokine serum levels in patients with plaque-type psoriasis","volume":"25","author":"Roussaki-Schulze","year":"2005","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB40|cit40","first-page":"165","article-title":"Activity of tumor necrosis factor-alfa (TNF-alpha) and selected acute phase proteins in plasma of psoriatic patients receiving local treatment","volume":"56","author":"Chodorowska","year":"2001","journal-title":"Ann Univ Mariae Curie Sklodowska [Med]"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0781.2008.00349.x","article-title":"Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, re-PUVA and narrow-band UVB","volume":"24","author":"Akman","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00403-006-0723-8","article-title":"Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman\u2019s therapy","volume":"298","author":"Andrys","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0781.2004.00089.x","article-title":"Whole-body UVB (TL-01) or UVA-1 irradiation does not alter the levels of immunomodulatory cytokines in the serum of human volunteers","volume":"20","author":"McLoone","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00403-005-0565-9","article-title":"Narrowband-UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells","volume":"297","author":"Sigmundsdottir","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.0906-6705.2004.00246.x","article-title":"Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers - IL-12, IL-18 and IL-23","volume":"13","author":"Piskin","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaad.2005.04.035","article-title":"Psoriasis - recent advances in understanding its pathogenesis and treatment","volume":"53","author":"Krueger","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2010.09992.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1468-3083.2009.03527.x","article-title":"C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy","volume":"24","author":"Coimbra","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-3155-6-5","article-title":"A high sensitivity assay for the inflammatory marker C-reactive protein employing acoustic biosensing","volume":"6","author":"McBride","year":"2008","journal-title":"J Nanobiotechnology"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00439-007-0397-0","article-title":"Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis","volume":"122","author":"Capon","year":"2007","journal-title":"Hum Genet"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1358\/dot.2010.46.4.1464839","article-title":"Ustekinumab for the treatment of psoriasis","volume":"46","author":"Farhi","year":"2010","journal-title":"Drugs Today (Barc)"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB54|cit54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes","volume":"124","author":"Zaba","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000051608","article-title":"Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches","volume":"202","author":"Karrer","year":"2001","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2133.2005.06368.x","article-title":"Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1","volume":"152","author":"Yano","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09992.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/12034754020060S302","article-title":"Pathophysiology of psoriasis: science behind therapy","volume":"6","author":"Guenther","year":"2002","journal-title":"J Cutan Med Surg"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09992.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09992.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.09992.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T18:05:25Z","timestamp":1740420325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/163\/6\/1282\/6643891"}},"subtitle":["Psoriasis vulgaris cytokines and PUVA\/NB-UVB therapy"],"short-title":[],"issued":{"date-parts":[[2010,11,8]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09992.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,8]]}}}